Table 1.
Baseline characteristics of study participants
|
Control pharmacy |
Intervention pharmacy |
Total (n = 1226) frequency/mean difference (95% CI) | P value | |
|---|---|---|---|---|
| n = 607 | n = 619 | |||
| Gender |
|
|
|
|
| -Female |
328 (54.0%) |
306 (49.4%) |
634 (51.7%) |
0.107 |
| -Male |
279 (46.0%) |
313 (50.6%) |
592 (48.3%) |
|
| Age (years) |
30.12 (10.23) |
31.55 (11.46) |
1.42 (0.20-2.64) |
0.022 |
| Age group |
|
|
|
|
| -Adolescent |
65 (10.7%) |
73 (11.8%) |
138 (11.3%) |
0.548 |
| -Adult |
542 (89.3%) |
546 (88.2%) |
1088 (88.7%) |
|
| Level of education (whole population) |
|
|
|
|
| -Primary or less |
61 (10%) |
57 (9.2%) |
118 (9.6%) |
0.618 |
| -At least secondary |
546 (90%) |
562 (90.8%) |
1108 (90.4%) |
|
| Level of income |
|
|
|
|
| -Less than average income |
372 (61.3%) |
370 (60.5%) |
742 (60.5%) |
0.588 |
| -Average income or more |
235 (38.7%) |
249 (40.2%) |
484 (39.5%) |
|
| Reported last treatment for malaria |
|
|
|
|
| -Less than 6 months ago |
381 (62.8%) |
386 (62.4%) |
767 (62.6%) |
0.882 |
| -More than 6 months ago |
226 (37.2%) |
233 (37.6%) |
459 (37.4%) |
|
| Who recommended anti-malarial |
|
|
|
|
| -Self |
255 (42.0%) |
303 (48.9%) |
558 (45.5%) |
0.015 |
| -Health professional |
352 (58.0%) |
316 (51.1%) |
668 (54.5%) |
|
| Participants with a doctor’s prescription prior to purchase of anti-malarial |
169 (27.8%) |
52 (8.4%)) |
221 (18.0%) |
< 0.001 |
| Reported positive lab test prior to purchase of anti-malarial |
103 (17.0%) |
96 (15.5%) |
199 (16.2%) |
0.488 |
| History of fever in the last 48 hours | 394 (64.9%) | 166 (26.8%) | 560 (45.7%) | < 0.001 |